Hauptman et al., 2023) and less opportunity for physical activity and social interaction (Finlay et al., 2022), which may contribute to increased risk for conditions that contribute to cardiovascular disease (e.g., hypertension, diabetes)
For some people, however, maintaining weight loss without a GLP-1 remains a challenge, even with other options available
FOXO4-DRI Preclinical Evidence and Translational Challenges: From Mouse Models to Clinical Reality FOXO4-DRI demonstrated selective senolytic activity in the landmark Baar et al
Embarking on a weight loss journey can be a daunting task
Compounded tirzepatide is often provided in a vial where the patient must draw up the medication themselves
The 25 th percentile indicates a duration of 1.2 years, while the 75 th percentile extends to 3.5 years, and the 90 th percentile reaches 4.3 years